Oleg S. Glotov

763 total citations
67 papers, 409 citations indexed

About

Oleg S. Glotov is a scholar working on Genetics, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Oleg S. Glotov has authored 67 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 23 papers in Molecular Biology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Oleg S. Glotov's work include Genomics and Rare Diseases (5 papers), Adipose Tissue and Metabolism (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Oleg S. Glotov is often cited by papers focused on Genomics and Rare Diseases (5 papers), Adipose Tissue and Metabolism (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Oleg S. Glotov collaborates with scholars based in Russia, United States and Belarus. Oleg S. Glotov's co-authors include Аndrey S. Glotov, В. С. Баранов, Yury A. Barbitoff, Dmitrii E. Polev, Alexander V. Predeus, Andrey Sudarikov, А. В. Чудинов, Eugene Nikitin, Yulia A. Nasykhova and Ildus I. Ahmetov and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Oleg S. Glotov

58 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oleg S. Glotov Russia 11 161 127 40 40 40 67 409
Ja Hye Kim South Korea 15 239 1.5× 193 1.5× 24 0.6× 53 1.3× 86 2.1× 68 553
Nurten Kara Türkiye 15 147 0.9× 117 0.9× 25 0.6× 47 1.2× 66 1.6× 48 580
Mariona Guitart‐Mampel Spain 17 252 1.6× 53 0.4× 58 1.4× 67 1.7× 92 2.3× 40 578
Yongjie Zhao China 9 127 0.8× 41 0.3× 20 0.5× 19 0.5× 71 1.8× 27 504
Roberto Quadrelli United States 10 345 2.1× 186 1.5× 48 1.2× 72 1.8× 20 0.5× 26 602
Areez Shafqat Saudi Arabia 14 132 0.8× 21 0.2× 36 0.9× 19 0.5× 48 1.2× 45 454
Teresa Micillo Italy 12 141 0.9× 64 0.5× 12 0.3× 12 0.3× 83 2.1× 19 521
Roxana Popescu Romania 9 88 0.5× 65 0.5× 23 0.6× 45 1.1× 43 1.1× 39 270
Eleonora Leggiero Italy 12 172 1.1× 56 0.4× 39 1.0× 13 0.3× 48 1.2× 16 325
Nobuyuki Kuwabara Japan 14 92 0.6× 35 0.3× 31 0.8× 16 0.4× 28 0.7× 31 493

Countries citing papers authored by Oleg S. Glotov

Since Specialization
Citations

This map shows the geographic impact of Oleg S. Glotov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oleg S. Glotov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oleg S. Glotov more than expected).

Fields of papers citing papers by Oleg S. Glotov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oleg S. Glotov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oleg S. Glotov. The network helps show where Oleg S. Glotov may publish in the future.

Co-authorship network of co-authors of Oleg S. Glotov

This figure shows the co-authorship network connecting the top 25 collaborators of Oleg S. Glotov. A scholar is included among the top collaborators of Oleg S. Glotov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oleg S. Glotov. Oleg S. Glotov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Голубенко, М. В., et al.. (2024). A New Leu714Arg Variant in the Converter Domain of MYH7 is Associated with a Severe Form of Familial Hypertrophic Cardiomyopathy. Frontiers in Bioscience-Scholar. 16(1). 1–1. 1 indexed citations
2.
Barbitoff, Yury A., Ekaterina Pomerantseva, Dmitrii E. Polev, et al.. (2024). Expanding the Russian allele frequency reference via cross-laboratory data integration: insights from 7452 exome samples. National Science Review. 11(10). nwae326–nwae326. 9 indexed citations
4.
Barbitoff, Yury A., et al.. (2024). Exome sequencing in extreme altitude mountaineers identifies pathogenic variants in RTEL1 and COL6A1 previously associated with respiratory failure. Physiological Reports. 12(8). e16015–e16015. 1 indexed citations
5.
Glotov, Oleg S., et al.. (2024). The Benefits of Whole-Exome Sequencing in the Differential Diagnosis of Hypophosphatasia. International Journal of Molecular Sciences. 25(21). 11728–11728.
6.
Komissarov, Aleksey, et al.. (2023). The Telomeric Repeats of HHV-6A Do Not Determine the Chromosome into Which the Virus Is Integrated. Genes. 14(2). 521–521. 1 indexed citations
7.
Polev, Dmitrii E., et al.. (2023). Evaluation of Gut Microbiota in Healthy Persons and Type 1 Diabetes Mellitus Patients in North-Western Russia. Microorganisms. 11(7). 1813–1813. 4 indexed citations
10.
Glotov, Аndrey S., et al.. (2022). Development of a biobank in the structure of scientific and diagnostic and treatment institutions and prospects for interregional integration. CARDIOVASCULAR THERAPY AND PREVENTION. 21(11). 3401–3401. 2 indexed citations
11.
Ivanov, Dmitry O., et al.. (2022). Next generation sequencing in the differential diagnosis of diabetes mellitus in children. Voprosy praktičeskoj pediatrii. 17(1). 84–94. 1 indexed citations
12.
Glotov, Oleg S., et al.. (2021). The application of Nanopore sequencing for variant calling on the human mitochondrial DNA. Biological Communications. 66(2). 1 indexed citations
13.
Glotov, Oleg S., et al.. (2021). Major predictive risk factors for а cytokine storm in COVID-19 patients (a retrospective clinical trials). SHILAP Revista de lepidopterología. 12(1). 5–15.
14.
Saifitdinova, Alsu, et al.. (2020). Mosaicism in preimplantation human embryos. SHILAP Revista de lepidopterología. 1(3). 225–230. 1 indexed citations
15.
Иванова, О.Н., Yury A. Barbitoff, В. С. Гуревич, et al.. (2020). Identification of novel variants in the LDLR gene in Russian patients with familial hypercholesterolemia using targeted sequencing. Biomedical Reports. 14(1). 15–15. 14 indexed citations
16.
Barbitoff, Yury A., Yulia A. Nasykhova, Dmitrii E. Polev, et al.. (2019). Whole‐exome sequencing provides insights into monogenic disease prevalence in Northwest Russia. Molecular Genetics & Genomic Medicine. 7(11). 25 indexed citations
17.
Barbitoff, Yury A., Yulia A. Nasykhova, Alexander V. Predeus, et al.. (2018). Identification of Novel Candidate Markers of Type 2 Diabetes and Obesity in Russia by Exome Sequencing with a Limited Sample Size. Genes. 9(8). 415–415. 24 indexed citations
18.
Баранов, В. С., et al.. (2014). New genetic and epigenetic approaches in gerontology. Advances in Gerontology. 4(4). 238–246. 3 indexed citations
19.
Glotov, Аndrey S., et al.. (2011). Association study of APOE, LPL and NOS3 polymorphisms with the risk of common cardio pathology in children and pregnant women. SHILAP Revista de lepidopterología. 9(4). 25–34. 2 indexed citations
20.
Оганов, В. С., О. Л. Виноградова, В. С. Баранов, et al.. (2008). Correlation between the bone mass of athletes and biochemical and genetic markers of bone tissue remodeling. Human Physiology. 34(2). 182–190. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026